Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
MDM2 is an E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome []. p53 acts as an important defense mechanism against cancer, and is negatively regulated by interaction with the oncoprotein MDM2 []. MDM2 overexpression correlates with metastasis and advanced forms of several cancers and may be used as a cancer drug target []. In addition, MDM2 has important roles in the cell independent of p53. It interacts with several proteins such as Rb/E2F-1 complex [], the DNA methyltransferase DNMT3A [], p107 [], MTBP []and the cyclin kinase inhibitor p21 []. MDM2 also affects cell apoptosis [, ]. The core of MDM2 folds into an open bundle of four helices which is capped by two small 3-strandedβ-sheets. It consists of a duplication of two structural repeats. MDM2 has a deep hydrophobic cleft on which the p53 α-helix binds; p53 residues involved in transactivation are buried deep within the cleft of MDM2, thereby concealing the p53 transactivation domain. In addition to its N-terminal p53 binding domain, MDM2 contains a central acidic domain, zinc finger domain and a C-terminal RING-finger domain. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Bouska A |
Year: |
2008 |
Journal: |
Mol Cell Biol |
Title: |
Mdm2 promotes genetic instability and transformation independent of p53. |
Volume: |
28 |
Issue: |
15 |
Pages: |
4862-74 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
489
 |
Fragment?: |
false |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3842086 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-09-29 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1679916 |
Pattern: |
Not Specified |
Stage: |
TS16 |
Assay Id: |
MGI:6763229 |
Age: |
embryonic day 10.0 |
Image: |
7A MDM2 Control |
|
Specimen Label: |
7A MDM2 Control |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
489
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
487
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu H |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change. |
Volume: |
285 |
Issue: |
24 |
Pages: |
18407-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gu L |
Year: |
2009 |
Journal: |
Cancer Cell |
Title: |
Regulation of XIAP translation and induction by MDM2 following irradiation. |
Volume: |
15 |
Issue: |
5 |
Pages: |
363-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dubs-Poterszman MC |
Year: |
1995 |
Journal: |
Oncogene |
Title: |
MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest. |
Volume: |
11 |
Issue: |
11 |
Pages: |
2445-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fu W |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. |
Volume: |
284 |
Issue: |
21 |
Pages: |
13987-4000 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tang YA |
Year: |
2012 |
Journal: |
Clin Cancer Res |
Title: |
MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer. |
Volume: |
18 |
Issue: |
16 |
Pages: |
4325-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brady M |
Year: |
2005 |
Journal: |
Mol Cell Biol |
Title: |
Regulation of p53 and MDM2 activity by MTBP. |
Volume: |
25 |
Issue: |
2 |
Pages: |
545-53 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3842086 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-09-29 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1679916 |
|
Stage: |
TS16 |
Assay Id: |
MGI:6763229 |
Age: |
embryonic day 10.0 |
Image: |
7A MDM2 LE; M2 f/f; p53 f/f |
|
Specimen Label: |
7A MDM2 LE; M2 f/f; p53 f/f |
Detected: |
false |
Specimen Num: |
2 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nag S |
Year: |
2013 |
Journal: |
J Biomed Res |
Title: |
The MDM2-p53 pathway revisited. |
Volume: |
27 |
Issue: |
4 |
Pages: |
254-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Moll UM |
Year: |
2003 |
Journal: |
Mol Cancer Res |
Title: |
The MDM2-p53 interaction. |
Volume: |
1 |
Issue: |
14 |
Pages: |
1001-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
de Oca Luna RM |
Year: |
1996 |
Journal: |
Genomics |
Title: |
The organization and expression of the mdm2 gene. |
Volume: |
33 |
Issue: |
3 |
Pages: |
352-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Olivos DJ 3rd |
Year: |
2018 |
Journal: |
J Cell Biochem |
Title: |
The proto-oncogene function of Mdm2 in bone. |
Volume: |
119 |
Issue: |
11 |
Pages: |
8830-8840 |
|
•
•
•
•
•
|
Publication |
First Author: |
Elkholi R |
Year: |
2019 |
Journal: |
Mol Cell |
Title: |
MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network. |
Volume: |
74 |
Issue: |
3 |
Pages: |
452-465.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bernardi R |
Year: |
2004 |
Journal: |
Nat Cell Biol |
Title: |
PML regulates p53 stability by sequestering Mdm2 to the nucleolus. |
Volume: |
6 |
Issue: |
7 |
Pages: |
665-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Boyd MT |
Year: |
2000 |
Journal: |
J Biol Chem |
Title: |
A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2. |
Volume: |
275 |
Issue: |
41 |
Pages: |
31883-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Freedman DA |
Year: |
1999 |
Journal: |
Cell Mol Life Sci |
Title: |
Functions of the MDM2 oncoprotein. |
Volume: |
55 |
Issue: |
1 |
Pages: |
96-107 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tompkins VS |
Year: |
2007 |
Journal: |
J Biol Chem |
Title: |
A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability. |
Volume: |
282 |
Issue: |
2 |
Pages: |
1322-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jones SN |
Year: |
1998 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. |
Volume: |
95 |
Issue: |
26 |
Pages: |
15608-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maguire M |
Year: |
2008 |
Journal: |
Cancer Res |
Title: |
MDM2 regulates dihydrofolate reductase activity through monoubiquitination. |
Volume: |
68 |
Issue: |
9 |
Pages: |
3232-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Steinman HA |
Year: |
2005 |
Journal: |
Oncogene |
Title: |
Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development. |
Volume: |
24 |
Issue: |
53 |
Pages: |
7935-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alt JR |
Year: |
2003 |
Journal: |
EMBO J |
Title: |
Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. |
Volume: |
22 |
Issue: |
6 |
Pages: |
1442-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Haupt Y |
Year: |
1997 |
Journal: |
Nature |
Title: |
Mdm2 promotes the rapid degradation of p53. |
Volume: |
387 |
Issue: |
6630 |
Pages: |
296-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang P |
Year: |
2008 |
Journal: |
Oncogene |
Title: |
Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells. |
Volume: |
27 |
Issue: |
11 |
Pages: |
1590-8 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Publication |
First Author: |
Reinke V |
Year: |
1999 |
Journal: |
Cell Growth Differ |
Title: |
Overproduction of MDM2 in vivo disrupts S phase independent of E2F1. |
Volume: |
10 |
Issue: |
3 |
Pages: |
147-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2014 |
Journal: |
J Pathol |
Title: |
Tissue-specific and age-dependent effects of global Mdm2 loss. |
Volume: |
233 |
Issue: |
4 |
Pages: |
380-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wunderlich M |
Year: |
2002 |
Journal: |
Oncogene |
Title: |
Mdm2 inhibition of p53 induces E2F1 transactivation via p21. |
Volume: |
21 |
Issue: |
28 |
Pages: |
4414-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mosner J |
Year: |
1994 |
Journal: |
Oncogene |
Title: |
p53 and mdm2 are expressed independently during cellular proliferation. |
Volume: |
9 |
Issue: |
11 |
Pages: |
3321-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
He J |
Year: |
2023 |
Journal: |
Life Sci |
Title: |
USP13 regulates cell senescence through mediating MDM2 stability. |
Volume: |
331 |
|
Pages: |
122044 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shostak K |
Year: |
2014 |
Journal: |
Cell Death Differ |
Title: |
MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation. |
Volume: |
21 |
Issue: |
5 |
Pages: |
811-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fridman JS |
Year: |
2003 |
Journal: |
Cancer Res |
Title: |
Tumor promotion by Mdm2 splice variants unable to bind p53. |
Volume: |
63 |
Issue: |
18 |
Pages: |
5703-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamauchi T |
Year: |
2014 |
Journal: |
Mol Cell Biol |
Title: |
MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24. |
Volume: |
34 |
Issue: |
17 |
Pages: |
3321-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hakobyan N |
Year: |
2004 |
Journal: |
Blood |
Title: |
Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. |
Volume: |
104 |
Issue: |
7 |
Pages: |
2060-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chinnam M |
Year: |
2022 |
Journal: |
PLoS Genet |
Title: |
MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity. |
Volume: |
18 |
Issue: |
5 |
Pages: |
e1010171 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dang J |
Year: |
2002 |
Journal: |
Cancer Res |
Title: |
The RING domain of Mdm2 can inhibit cell proliferation. |
Volume: |
62 |
Issue: |
4 |
Pages: |
1222-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Juven-Gershon T |
Year: |
1998 |
Journal: |
Mol Cell Biol |
Title: |
The Mdm2 oncoprotein interacts with the cell fate regulator Numb. |
Volume: |
18 |
Issue: |
7 |
Pages: |
3974-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hallenborg P |
Year: |
2012 |
Journal: |
Cell Death Differ |
Title: |
Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation. |
Volume: |
19 |
Issue: |
8 |
Pages: |
1381-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Coutts AS |
Year: |
2007 |
Journal: |
EMBO Rep |
Title: |
Mdm2 targets the p53 transcription cofactor JMY for degradation. |
Volume: |
8 |
Issue: |
1 |
Pages: |
84-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang CJ |
Year: |
2004 |
Journal: |
J Biol Chem |
Title: |
PTEN regulates Mdm2 expression through the P1 promoter. |
Volume: |
279 |
Issue: |
28 |
Pages: |
29841-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Arena G |
Year: |
2018 |
Journal: |
Mol Cell |
Title: |
Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53. |
Volume: |
69 |
Issue: |
4 |
Pages: |
594-609.e8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maetens M |
Year: |
2007 |
Journal: |
Blood |
Title: |
Distinct roles of Mdm2 and Mdm4 in red cell production. |
Volume: |
109 |
Issue: |
6 |
Pages: |
2630-3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Léveillard T |
Year: |
1998 |
Journal: |
Mech Dev |
Title: |
MDM2 expression during mouse embryogenesis and the requirement of p53. |
Volume: |
74 |
Issue: |
1-2 |
Pages: |
189-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ortiz GJ |
Year: |
2018 |
Journal: |
Oncogene |
Title: |
Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes. |
Volume: |
37 |
Issue: |
3 |
Pages: |
332-340 |
|
•
•
•
•
•
|
Publication |
First Author: |
Steinman HA |
Year: |
2002 |
Journal: |
Genesis |
Title: |
Generation of an Mdm2 conditional allele in mice. |
Volume: |
32 |
Issue: |
2 |
Pages: |
142-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Grier JD |
Year: |
2002 |
Journal: |
Genesis |
Title: |
Conditional allele of mdm2 which encodes a p53 inhibitor. |
Volume: |
32 |
Issue: |
2 |
Pages: |
145-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen L |
Year: |
2010 |
Journal: |
EMBO J |
Title: |
MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output. |
Volume: |
29 |
Issue: |
15 |
Pages: |
2538-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou S |
Year: |
2011 |
Journal: |
Mol Cell Biol |
Title: |
MDM2 regulates vascular endothelial growth factor mRNA stabilization in hypoxia. |
Volume: |
31 |
Issue: |
24 |
Pages: |
4928-37 |
|
•
•
•
•
•
|
Publication |
First Author: |
Barak Y |
Year: |
1993 |
Journal: |
EMBO J |
Title: |
mdm2 expression is induced by wild type p53 activity. |
Volume: |
12 |
Issue: |
2 |
Pages: |
461-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Terzian T |
Year: |
2007 |
Journal: |
Mol Cell Biol |
Title: |
Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development. |
Volume: |
27 |
Issue: |
15 |
Pages: |
5479-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Barboza JA |
Year: |
2008 |
Journal: |
Mol Cancer Res |
Title: |
Mdm2 and Mdm4 loss regulates distinct p53 activities. |
Volume: |
6 |
Issue: |
6 |
Pages: |
947-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Steinman HA |
Year: |
2004 |
Journal: |
J Biol Chem |
Title: |
An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis. |
Volume: |
279 |
Issue: |
6 |
Pages: |
4877-86 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lundgren K |
Year: |
1997 |
Journal: |
Genes Dev |
Title: |
Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. |
Volume: |
11 |
Issue: |
6 |
Pages: |
714-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dias SS |
Year: |
2009 |
Journal: |
FEBS Lett |
Title: |
Polo-like kinase-1 phosphorylates MDM2 at Ser260 and stimulates MDM2-mediated p53 turnover. |
Volume: |
583 |
Issue: |
22 |
Pages: |
3543-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Grier JD |
Year: |
2006 |
Journal: |
Mol Cell Biol |
Title: |
Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4. |
Volume: |
26 |
Issue: |
1 |
Pages: |
192-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsai NP |
Year: |
2017 |
Journal: |
Hum Mol Genet |
Title: |
FMRP-dependent Mdm2 dephosphorylation is required for MEF2-induced synapse elimination. |
Volume: |
26 |
Issue: |
2 |
Pages: |
293-304 |
|
•
•
•
•
•
|
Publication |
First Author: |
Clegg HV |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction. |
Volume: |
7 |
Issue: |
5 |
Pages: |
e38212 |
|
•
•
•
•
•
|
Publication |
First Author: |
Veldhoen N |
Year: |
1999 |
Journal: |
Oncogene |
Title: |
A novel exon within the mdm2 gene modulates translation initiation in vitro and disrupts the p53-binding domain of mdm2 protein. |
Volume: |
18 |
Issue: |
50 |
Pages: |
7026-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hilliard SA |
Year: |
2014 |
Journal: |
Dev Biol |
Title: |
Mdm2 is required for maintenance of the nephrogenic niche. |
Volume: |
387 |
Issue: |
1 |
Pages: |
1-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mendrysa SM |
Year: |
2001 |
Journal: |
Gene |
Title: |
Characterization of the 5' and 3' untranslated regions in murine mdm2 mRNAs. |
Volume: |
264 |
Issue: |
1 |
Pages: |
139-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fakharzadeh SS |
Year: |
1993 |
Journal: |
Genomics |
Title: |
Structure and organization of amplified DNA on double minutes containing the mdm2 oncogene. |
Volume: |
15 |
Issue: |
2 |
Pages: |
283-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Thomasova D |
Year: |
2016 |
Journal: |
Cell Death Dis |
Title: |
MDM2 prevents spontaneous tubular epithelial cell death and acute kidney injury. |
Volume: |
7 |
Issue: |
11 |
Pages: |
e2482 |
|
•
•
•
•
•
|
Publication |
First Author: |
Salcedo A |
Year: |
2006 |
Journal: |
EMBO J |
Title: |
Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. |
Volume: |
25 |
Issue: |
20 |
Pages: |
4752-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Götz C |
Year: |
2005 |
Journal: |
Int J Oncol |
Title: |
Phosphorylation of mdm2 at serine 269 impairs its interaction with the retinoblastoma protein. |
Volume: |
26 |
Issue: |
3 |
Pages: |
801-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang H |
Year: |
2012 |
Journal: |
Cell Cycle |
Title: |
Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection. |
Volume: |
11 |
Issue: |
3 |
Pages: |
582-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
O'Leary KA |
Year: |
2004 |
Journal: |
Mol Cell Biol |
Title: |
Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues. |
Volume: |
24 |
Issue: |
1 |
Pages: |
186-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Feeley KP |
Year: |
2017 |
Journal: |
Cancer Res |
Title: |
Mdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells. |
Volume: |
77 |
Issue: |
14 |
Pages: |
3823-3833 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang P |
Year: |
2006 |
Journal: |
Oncogene |
Title: |
Decreased Mdm2 expression inhibits tumor development induced by loss of ARF. |
Volume: |
25 |
Issue: |
26 |
Pages: |
3708-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Foster CJ |
Year: |
2002 |
Journal: |
Oncogene |
Title: |
Loss of p19ARF enhances the defects of Mdm2 overexpression in the mammary gland. |
Volume: |
21 |
Issue: |
22 |
Pages: |
3525-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Singh S |
Year: |
2013 |
Journal: |
Cell Death Differ |
Title: |
Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells. |
Volume: |
20 |
Issue: |
4 |
Pages: |
558-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee D |
Year: |
2012 |
Journal: |
EMBO Rep |
Title: |
Mdm2 associates with Ras effector NORE1 to induce the degradation of oncoprotein HIPK1. |
Volume: |
13 |
Issue: |
2 |
Pages: |
163-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zou Q |
Year: |
2014 |
Journal: |
Nat Immunol |
Title: |
USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. |
Volume: |
15 |
Issue: |
6 |
Pages: |
562-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jean-Charles PY |
Year: |
2017 |
Journal: |
JCI Insight |
Title: |
Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptor signaling. |
Volume: |
2 |
Issue: |
17 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang J |
Year: |
2020 |
Journal: |
FASEB J |
Title: |
Mdm2 is a target and mediator of IRP2 in cell growth control. |
Volume: |
34 |
Issue: |
2 |
Pages: |
2301-2311 |
|
•
•
•
•
•
|
Publication |
First Author: |
RodrÃguez C |
Year: |
2018 |
Journal: |
Stroke |
Title: |
Single-Nucleotide Polymorphism 309T>G in the MDM2 Promoter Determines Functional Outcome After Stroke. |
Volume: |
49 |
Issue: |
10 |
Pages: |
2437-2444 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ganguli G |
Year: |
2000 |
Journal: |
EMBO J |
Title: |
MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis. |
Volume: |
19 |
Issue: |
19 |
Pages: |
5135-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Malek R |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
The p53 inhibitor MDM2 facilitates Sonic Hedgehog-mediated tumorigenesis and influences cerebellar foliation. |
Volume: |
6 |
Issue: |
3 |
Pages: |
e17884 |
|
•
•
•
•
•
|
Publication |
First Author: |
Moumen A |
Year: |
2007 |
Journal: |
Development |
Title: |
Met acts on Mdm2 via mTOR to signal cell survival during development. |
Volume: |
134 |
Issue: |
7 |
Pages: |
1443-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Humpton TJ |
Year: |
2021 |
Journal: |
Genes Dev |
Title: |
Differential requirements for MDM2 E3 activity during embryogenesis and in adult mice. |
Volume: |
35 |
Issue: |
1-2 |
Pages: |
117-132 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jones SN |
Year: |
1996 |
Journal: |
Gene |
Title: |
Genomic organization of the mouse double minute 2 gene. |
Volume: |
175 |
Issue: |
1-2 |
Pages: |
209-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou J |
Year: |
2021 |
Journal: |
Nat Immunol |
Title: |
The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity. |
Volume: |
22 |
Issue: |
4 |
Pages: |
460-470 |
|
•
•
•
•
•
|
Publication |
First Author: |
Juven T |
Year: |
1993 |
Journal: |
Oncogene |
Title: |
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. |
Volume: |
8 |
Issue: |
12 |
Pages: |
3411-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Masuhara M |
Year: |
2003 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Enhanced degradation of MDM2 by a nuclear envelope component, mouse germ cell-less. |
Volume: |
308 |
Issue: |
4 |
Pages: |
927-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Han NR |
Year: |
2014 |
Journal: |
J Invest Dermatol |
Title: |
TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6. |
Volume: |
134 |
Issue: |
10 |
Pages: |
2521-2530 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lai KP |
Year: |
2010 |
Journal: |
EMBO J |
Title: |
S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response. |
Volume: |
29 |
Issue: |
17 |
Pages: |
2994-3006 |
|
•
•
•
•
•
|